Biotherapix SLU - Product Pipeline Review - 2012

 Published On: Dec, 2012 |    No of Pages: 24 |  Published By: Global Markets Direct | Format: PDF
Request Free Sample


“Biotherapix SLU - Product Pipeline Review - 2012” provides data on the Biotherapix SLU’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Biotherapix SLU’s corporate website, SEC filings, investor presentations and featured press releases, both from Biotherapix SLU and industry-specific third party sources, put together by Global Markets Direct’s team.


- Biotherapix SLU - Brief Biotherapix SLU overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biotherapix SLU human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Biotherapix SLU with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Biotherapix SLU’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Biotherapix SLU’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Biotherapix SLU in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Biotherapix SLU’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Biotherapix SLU.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Biotherapix SLU and identify potential opportunities in those areas.

Table of Contents 2
List of Tables 4
List of Figures 4
Biotherapix SLU Snapshot 5
Biotherapix SLU Overview 5
Key Information 5
Key Facts 5
Biotherapix SLU – Research and Development Overview 6
Key Therapeutic Areas 6
Biotherapix SLU – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Biotherapix SLU – Pipeline Products Glance 10
Biotherapix SLU – Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Biotherapix SLU – Drug Profiles 11
Btx-201 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Btx-301 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Btx-401 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Btx-402 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Btx-403 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Btx-404 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Btx-405 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Btx-501 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Btx-502 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Biotherapix SLU – Locations And Subsidiaries 20
Head Office 20
Financial Deals Landscape 21
Biotherapix SLU, Deals Summary 21
Biotherapix SLU, Pharmaceuticals & Healthcare, Deal Details 22
Partnerships 22
Biotherapix Enters Into Co-Development Agreement With Digna Biotech 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
Biotherapix SLU, Key Information 5
Biotherapix SLU, Key Facts 5
Biotherapix SLU – Pipeline by Indication, 2012 7
Biotherapix SLU – Pipeline by Stage of Development, 2012 8
Biotherapix SLU – Monotherapy Products in Pipeline, 2012 9
Biotherapix SLU – Pre-Clinical, 2012 10
Biotherapix SLU, Deals Summary 21
Biotherapix Enters Into Co-Development Agreement With Digna Biotech 22

List of Figures
Biotherapix SLU – Pipeline by Indication, 2012 7
Biotherapix SLU – Pipeline by Stage of Development, 2012 8
Biotherapix SLU – Monotherapy Products in Pipeline, 2012 9

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.